Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Cooling inflammation while potentiating immune checkpoint inhibition: Enhancing the benefit–risk ratio of immuno-oncology therapy
Potter, D. A., Guo, Z., Lei, J. & Antonarakis, E. S., Feb 27 2024, In: Proceedings of the National Academy of Sciences of the United States of America. 121, 9, e2400431121.Research output: Contribution to journal › Comment/debate › peer-review
-
Development of an International Virtual Multidisciplinary Tumor Board for Breast Cancer in Mongolia
Brownson, K. E., Flores-Huidobro Martinez, A., Ganbayar, J., Sorensen, L. M., Darelli-Anderson, A. M., Prathibha, S., Hoven, N., Nansalmaa, E., Mahlow, J., Pushkin, B., Potter, D., Tuttle, T. & Price, R. R., Mar 2024, In: Journal of Surgical Research. 295, p. 776-782 7 p.Research output: Contribution to journal › Article › peer-review
-
Endothelial dysfunction in breast cancer survivors on aromatase inhibitors: changes over time
Shaaban, A., Petersen, A., Beckwith, H., Florea, N., Potter, D. A., Yee, D., Vogel, R. I., Duprez, D. & Blaes, A. H., Dec 2024, In: Cardio-Oncology. 10, 1, 27.Research output: Contribution to journal › Article › peer-review
Open Access -
Impact of body mass index on pathological response after neoadjuvant chemotherapy: results from the I-SPY 2 trial
I-SPY 2 Trial Consortium, Apr 2024, In: Breast Cancer Research and Treatment. 204, 3, p. 589-597 9 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial-Efficacy and Biomarker Discovery
Albain, K. S., Yau, C., Petricoin, E. F., Wolf, D. M., Lang, J. E., Chien, A. J., Haddad, T., Forero-Torres, A., Wallace, A. M., Kaplan, H., Pusztai, L., Euhus, D., Nanda, R., Elias, A. D., Clark, A. S., Godellas, C., Boughey, J. C., Isaacs, C., Tripathy, D. & Lu, J. & 29 others, , Feb 15 2024, In: Clinical Cancer Research. 30, 4, p. 729-740 12 p.Research output: Contribution to journal › Article › peer-review
3 Scopus citations